|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product | |||||
| License | |||||
| Royalty | |||||
| Total revenue | |||||
| Costs and expenses: | |||||
| Cost of sales | |||||
| Selling, general and administrative expenses | |||||
| Total cost of sales and SG&A | |||||
| Operating loss | |||||
| Other income: | |||||
| Settlement of litigation | |||||
| Interest income, net | |||||
| Income from governmental assistance program | |||||
| (Loss) before income taxes | |||||
| Provision for income tax expense | |||||
| Net (loss) | |||||
| Basic (loss) per share (in dollars per share) | |||||
| Diluted (loss) per share (in dollars per share) | |||||
| Weighted average shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...